These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35279358)

  • 1. Barriers and poor telephone counseling experiences among patients receiving medication for opioid use disorders.
    Kang AW; DeBritz AA; Hoadley A; DelaCuesta C; Walton M; Hurley L; Martin R
    Patient Educ Couns; 2022 Jul; 105(7):2607-2610. PubMed ID: 35279358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication for Opioid Use Disorder Service Provision and Telephone Counseling: A Concurrent Mixed-Methods Approach.
    Martin R; Kang AW; DeBritz AA; Walton MR; Hoadley A; DelaCuesta C; Hurley L
    Int J Environ Res Public Health; 2021 Jun; 18(11):. PubMed ID: 34200312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The provision of counseling to patients receiving medications for opioid use disorder: Telehealth innovations and challenges in the age of COVID-19.
    Hughto JMW; Peterson L; Perry NS; Donoyan A; Mimiaga MJ; Nelson KM; Pantalone DW
    J Subst Abuse Treat; 2021 Jan; 120():108163. PubMed ID: 33298301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
    Jones CM; Shoff C; Hodges K; Blanco C; Losby JL; Ling SM; Compton WM
    JAMA Psychiatry; 2022 Oct; 79(10):981-992. PubMed ID: 36044198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of and Retention on Video, Telephone, and In-Person Buprenorphine Treatment for Opioid Use Disorder During the COVID-19 Pandemic.
    Frost MC; Zhang L; Kim HM; Lin LA
    JAMA Netw Open; 2022 Oct; 5(10):e2236298. PubMed ID: 36223118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient Experiences with the Transition to Telephone Counseling during the COVID-19 Pandemic.
    Kang AW; Walton M; Hoadley A; DelaCuesta C; Hurley L; Martin R
    Healthcare (Basel); 2021 Jun; 9(6):. PubMed ID: 34199582
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical genetic counselor experience in the adoption of telehealth in the United States and Canada during the COVID-19 pandemic.
    Ma D; Ahimaz PR; Mirocha JM; Cook L; Giordano JL; Mohan P; Cohen SA
    J Genet Couns; 2021 Oct; 30(5):1214-1223. PubMed ID: 34757671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telemedicine for contraceptive counseling: Patient experiences during the early phase of the COVID-19 pandemic in New York City.
    Stifani BM; Smith A; Avila K; Boos EW; Ng J; Levi EE; Benfield NC
    Contraception; 2021 Sep; 104(3):254-261. PubMed ID: 33861981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transitioning to telegenetics in the COVID-19 era: Patient satisfaction with remote genetic counseling in adult neurology.
    Dratch L; Paul RA; Baldwin A; Brzozowski M; Gonzalez-Alegre P; Tropea TF; Raper A; Bardakjian T
    J Genet Couns; 2021 Aug; 30(4):974-983. PubMed ID: 34265143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient Characteristics Associated With Phone Versus Video Telemedicine Visits for Substance Use Treatment during COVID-19.
    Chang JE; Lindenfeld Z; Thomas T; Waldman J; Griffin J
    J Addict Med; 2022 Nov-Dec 01; 16(6):659-665. PubMed ID: 35195540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An examination of telehealth policy impacts on initial rural opioid use disorder treatment patterns during the COVID-19 pandemic.
    Hughes PM; Verrastro G; Fusco CW; Wilson CG; Ostrach B
    J Rural Health; 2021 Jun; 37(3):467-472. PubMed ID: 33720447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Red Flags' and 'Red Tape': Telehealth and pharmacy-level barriers to buprenorphine in the United States.
    Textor L; Ventricelli D; Aronowitz SV
    Int J Drug Policy; 2022 Jul; 105():103703. PubMed ID: 35561484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Access to medication for opioid use disorder supported by telemedicine and healthcare coverage: A web-based survey during the COVID-19 pandemic.
    Monnig MA; Clark SE; Treloar Padovano H; Sokolovsky AW; Goodyear K; Ahluwalia JS; Monti PM
    Addict Behav Rep; 2023 Dec; 18():100515. PubMed ID: 37731991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telehealth for opioid use disorder treatment in low-barrier clinic settings: an exploration of clinician and staff perspectives.
    Aronowitz SV; Engel-Rebitzer E; Dolan A; Oyekanmi K; Mandell D; Meisel Z; South E; Lowenstein M
    Harm Reduct J; 2021 Nov; 18(1):119. PubMed ID: 34823538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The COVID-19 pandemic and opioid use disorder: Expanding treatment with buprenorphine, and combining safety precautions with telehealth.
    Cales RH; Cales SC; Shreffler J; Huecker MR
    J Subst Abuse Treat; 2022 Feb; 133():108543. PubMed ID: 34210567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication treatment for opioid use disorder in the age of COVID-19: Can new regulations modify the opioid cascade?
    Nunes EV; Levin FR; Reilly MP; El-Bassel N
    J Subst Abuse Treat; 2021 Mar; 122():108196. PubMed ID: 33221125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syringe service program-based telemedicine linkage to opioid use disorder treatment: protocol for the STAMINA randomized control trial.
    Watson DP; Swartz JA; Robison-Taylor L; Mackesy-Amiti ME; Erwin K; Gastala N; Jimenez AD; Staton MD; Messmer S
    BMC Public Health; 2021 Mar; 21(1):630. PubMed ID: 33789642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Receipt of Opioid Use Disorder-Related Telehealth Services and Medications for Opioid Use Disorder With Fatal Drug Overdoses Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
    Jones CM; Shoff C; Blanco C; Losby JL; Ling SM; Compton WM
    JAMA Psychiatry; 2023 May; 80(5):508-514. PubMed ID: 36988913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of COVID-19 Telehealth Policy Changes on Buprenorphine Treatment for Opioid Use Disorder.
    Lin LA; Zhang L; Kim HM; Frost MC
    Am J Psychiatry; 2022 Oct; 179(10):740-747. PubMed ID: 35899380
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.